Trace Medical, a leader in advanced respiratory rentals and biomedical services, has made a significant equity investment in LiViliti Health Products, Inc. This partnership aims to enhance patient care management through innovative solutions in the respiratory health sector. The announcement was made on December 19, 2025, and represents a strategic alignment between the two companies, which both share a commitment to improving healthcare outcomes.
LiViliti, based in Sarasota, Florida, is recognized for its development of innovative CPAP and respiratory accessories. The collaboration will leverage LiViliti’s expertise in health cleaning products and Trace Medical’s established market presence. According to Greg Apostolou, Chief Executive Officer of Trace Medical, “LiViliti and Trace are a natural fit, leveraging LiViliti’s suite of health cleaning products and core expertise with Trace Medical’s infrastructure and market reach to collectively improve patient care management options.”
The partnership is expected to accelerate innovation and expand market reach, as highlighted by Brian Sharpe, Chief Executive Officer of LiViliti. He stated, “Working in collaboration with Trace Medical, we can accelerate innovation, expand our reach and better serve healthcare systems nationwide.” This collaboration will enable both companies to deliver more integrated and impactful solutions that support clinicians and protect patients across various care settings.
Elliot Campbell, Chief Commercial Officer of Trace Medical, expressed enthusiasm about the opportunities this partnership presents. He noted, “We are pleased with the opportunity to deliver LiViliti’s product solutions to customers across our shared customer base.” This sentiment is echoed by Jim Gilkison, Vice President of LiViliti, who mentioned that leveraging Trace Medical’s established footprint will significantly enhance their commercial expansion.
The two companies plan to initiate a coordinated go-to-market strategy starting in early 2026. This joint effort will align their commercial strategies, messaging, and outreach efforts, aiming to enhance their market presence and deliver greater value to healthcare providers and patients.
Founded in 2004, Trace Medical is recognized for its comprehensive range of services throughout the continuum of care, which includes skilled nursing facilities, rehabilitation centers, and hospice services. The company focuses on ensuring that patients have access to advanced respiratory solutions that meet their healthcare needs.
LiViliti Health Products, established in 2019, is dedicated to improving the experiences of CPAP therapy users. By focusing on hygiene, comfort, and compliance, LiViliti designs innovative solutions that help patients maintain cleaner equipment and adhere to their prescribed therapy.
This partnership between Trace Medical and LiViliti represents a significant advancement in the respiratory care landscape, promising to enhance patient outcomes through improved product offerings and expanded market access. For more information about Trace Medical, visit their website at www.TraceMedical.com.
